TRIP13 and hepatocellular carcinoma: In conclusion, our present data indicated that inhibitors targeting TRIP13 decreased the proliferation, migration, and invasion of HCC cells, inhibition of TRIP13 induced cell death and cell cycle arrest via suppressing DSB repair.